- Erratum
-
Kim YJ, Kim KT, Kim JH, Cha SD, Kim JW, Bae DS, Nam JH, Ahn WS, Choi HS, Ng T, Bi D, OK JJ, Descamps D, Bock HL
- KMID: 1792915
- J Korean Med Sci.
- 2010 Dec;25(12):1831-1831.
- doi: 10.3346/jkms.2010.25.12.1831
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Post-Marketing Surveillance Study of Hepatitis A Vaccine in Korean Population
-
Choi JW, Kim MS, Ma SH, Kang JH, Ok JJ, Ng TL, Bock HL, Havrixâ„¢ PMS Korean study group
- KMID: 2439921
- Korean J Pediatr Infect Dis.
- 2008 Dec;15(2):115-120.
- doi: 10.14776/kjpid.2008.15.2.115
PURPOSE: This post-marketing surveillance (PMS) study was conducted in Korea to assess the safety and reactogenicity of hepatitis A vaccine (GlaxoSmithKlineBiologicals'Havrixâ„¢) administered to the Korean population. METHODS: A total of 1,188... -
- CITED
-
- Close
- SHARE
-
- Close
- Post-marketing Surveillance Study of an Inactivated Split-Virion Influenza Vaccine in Korea
-
Huh JW, Ma SH, Kim HK, Gunapalaiah B, Bock HL, Fluarix-054 Study Group
- KMID: 2278966
- Korean J Pediatr Infect Dis.
- 2011 Jun;18(1):68-79.
PURPOSE: This post-marketing surveillance study (NCT00750360) assessed the safety and reactogenicity of an inactivated, trivalent split-virion influenza vaccine licensed for use in the Korea since 2002. METHODS: Eight hundred and eighty... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunogenicity, Reactogenicity and Safety of a Combined DTPa-IPV Vaccine Compared with Separate DTPa and IPV Vaccines in Healthy Korean Infants
-
Kim CH, Cha SH, Shin SM, Kim CS, Choi YY, Hong YJ, Chey MJ, Kim KN, Hur JK, Jo DS, Kim SS, Lee SL, Song ES, Ramakrishnan G, Ok JJ, Van Der Meeren O, Bock HL, Kim JS
- KMID: 2072433
- Korean J Pediatr Infect Dis.
- 2010 Dec;17(2):156-168.
PURPOSE: To compare immunogenicity and reactogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine (DTPa-IPV, Infanrix(TM) IPV, GlaxoSmithKline Biologicals) with co-administration of commercially available DTPa and IPV vaccines at separate injection... -
- CITED
-
- Close
- SHARE
-
- Close
- Human papillomavirus 16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in 15-25 years old healthy Korean women
-
Kim SC, Song YS, Kim YT, Kim YT, Ryu KS, Gunapalaiah B, Bi D, Bock HL, Park JS
- KMID: 2288569
- J Gynecol Oncol.
- 2011 Jun;22(2):67-75.
- doi: 10.3802/jgo.2011.22.2.67
OBJECTIVE: The study assessed the immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Korean women aged 15-25 years. METHODS: Phase IIIB, double-blind, randomised (2:1), multi-centre trial... -
- CITED
-
- Close
- SHARE
-
- Close
